81results about Bovine somatotropin companies
Sort by:
Most relevant
Bovine somatotropin or bovine somatotrophin (abbreviated bST and BST), or bovine growth hormone (BGH), is a peptide hormone produced by cows' pituitary glands. Like other hormones, it is produced in small quantities and is used in regulating metabolic processes. After the biotech company Genentech discovered and patented the gene for BST in the 1970s, it became possible to synthesize the hormone using recombinant DNA technology to create recombinant bovine somatotropin (rBST), recombinant bovine growth hormone (rBGH), or artificial growth hormone. Four large pharmaceutical companies, Monsanto, American Cyanamid, Eli Lilly, and Upjohn, developed commercial rBST products and submitted them to the US Food and Drug Administration (FDA) for approval. Monsanto was the first firm to receive approval. Other countries (Mexico, Brazil, India, Russia, and at least ten others) also approved rBST for commercial use. Monsanto licensed Genentech's patent, and marketed their product as "Posilac". In October 2008, Monsanto sold this business, in full, to Eli Lilly and Company for $300 million plus additional consideration.
Pharmacia & Upjohn Co. LLC
|
United States
|
-
|
-
|
Subsidiary Company
Pharmacia & Upjohn Co. LLC, a subsidiary of Pfizer Inc., is a company headquartered in Bingham Farms, MI, that manufactures and supplies pharmaceutical goods.
More
Drug
Eli Lilly & Co.
1876
|
United States
|
10,000-50,000
|
http://www.lilly.com
|
Public Company
Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.
More
Medicine
Humalog Mix
Major depressive disorder
Breast cancer
Insulin
Clinical trial
Oncology drugs
Insulin pen
Idiopathic short stature
Insulin aspart
Generalized anxiety disorder
Bipolar I disorder
Peripheral neuropathic pain
Bulimia nervosa
Panic disorder
Growth hormone deficiency
Endocrinology
Fibromyalgia
Monoclonal antibody
...[+16]
The Upjohn Co.
1886
|
United States
|
-
|
https://upjohn.net
|
Private Company
The Upjohn Company was a pharmaceutical manufacturing firm founded in 1886 in Kalamazoo, Michigan, by Dr. William E. Upjohn, an 1875 graduate of the University of Michigan medical school. The company was originally formed to make friable pills, which were specifically designed to be easily digested. These could be "reduced to a powder under the thumb", a strong marketing argument at the time.
More
Botanical drug
Herb
Genentech, Inc.
1976
|
United States
|
10,000-50,000
|
http://www.gene.com
|
Subsidiary Company
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline.
The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche.
Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.
More
Biotechnology
Biology
Medicine
Bevacizumab
Oncology drugs
Monoclonal antibody
Drug discovery
Rituximab
Immunotherapy
Biopharmaceutical
Cancer immunotherapy
Cisplatin
Paclitaxel
Pharmaceutical manufacturing
Genomics
Carboplatin
Cardiovascular agent
Biomedicine
Tocilizumab
Ixabepilone
...[+17]
Monsanto Co.
1901
|
United States
|
10,000-50,000
|
https://www.cropscience.bayer.com
|
Subsidiary Company
The Monsanto Company (/mɒnˈsæntoʊ/) was an American agrochemical and agricultural biotechnology corporation founded in 1901. In 2018, it was acquired by Bayer as part of its crop science division. It was headquartered in Creve Coeur, Missouri. Monsanto developed Roundup, a glyphosate-based herbicide, in the 1970s, and became a major producer of genetically engineered crops.
More
Pesticide
Agriculture
Farming industry
Weed control
Dicamba
Fungicide
Seed treatment
Agrochemical
Germplasm
Agricultural productivity
Cropping
Biopesticide
Biotechnology
Crop
Soil treatment
Genomics
Trait
Glyphosate
Bioherbicide
Integrated pest management
...[+17]
Ambrx, Inc.
2003
|
United States
|
100-250
|
http://www.ambrx.com
|
Ambrx is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. These include next generation antibody drug conjugates (ADCs), bispecifics, targeted immuno-oncology therapies, novel cytokines to modulate the immune system, and long-acting therapeutic peptides for metabolic and cardiovascular disease. Ambrx is advancing a robust portfolio of clinical and preclinical programs designed to optimize efficacy, safety and ease of use, in multiple therapeutic areas, including its lead product candidate ARX788.
More
Biology
Pharmacy and Therapeutics
Dosing Frequency
Antibody-drug conjugate
Medicine
Protein therapeutics
Potency
Drug
Oncology drugs
Biopharmaceutical
Biotechnology
Monoclonal antibody
Biomedicine
Exosome
Drug discovery
Oncology
Prefilled Syringe
Autoinjector
Sewing needle
Injector
...[+17]
F. Hoffmann-La Roche Ltd.
1896
|
Switzerland
|
-
|
http://www.roche.com
|
Subsidiary Company
F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
More
Medicine
Drug
Clinical trial
Biopharmaceutical
Genomics
Cancer research
Oncology drugs
Diagnostic test
Polymerase chain reaction
Neuroscience
Oncology
Cancer
Clinical chemistry
Genetic testing
Molecular diagnostics
Immunochemistry
Hematology
Tuberculosis
Urinalysis
...[+16]
Yeda Research & Development Co. Ltd.
1959
|
Israel
|
10-50
|
http://www.yedarnd.com
|
Subsidiary Company
Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education.
- Identify and assess research projects with commercial potential.
- Protect the intellectual property of the Institute and its scientists.
- Create business relationships and license the Institute’s inventions and technologies to the industry.
- Channel funding from industry to research projects.
For further information please contact Tamir Huberman, CIO and Head of Marketing
More
Association (object-oriented programming)
Intellectual property
Biotechnology
Basic research
Biopharmaceutical
Biomedicine
Microbiome
Dementia
Immunotherapy
Biophysics
Oncology drugs
Clinical trial
...[+9]
Zydus Lifesciences Ltd.
1952
|
India
|
10,000-50,000
|
http://www.zyduscadila.com
|
Public Company
Zydus Lifesciences Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm's products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.
More
Medicine
Therapeutic protein
Monoclonal antibody
Clinical trial
Drug development
Drug discovery
Infection drug
Orphan drug
Pharmaceutical manufacturing
Gastrointestinal agent
Vitamin
Immunosuppressive drug
Sirolimus
Clobazam
Male infertility
Corticosteroid
Contract research organization
Biosimilar
Liposome
...[+16]
International Minerals & Chemical
|
United States
|
-
|
-
|
Private Company
Manufactures phosphate rock and fertilizers
More
Fertilizer
Agriculture
Chemical engineering
Sewage
LG Life Sciences Ltd.
2002
|
South Korea
|
250-500
|
https://www.lgls.co.kr
|
Private Company
LG Life Sciences Ltd. engages in the development, production and marketing medicine and fine chemicals. Its products include growth hormone products, arthritis medicine, diabetes medicine, cosmetic surgery products, hypertension treatment, synthetic medicinal raw materials, and pesticide raw material. The company was founded on August 1, 2002 and is headquartered in Seoul, South Korea.
More
Medicine
Medical equipment
Raw material
Drug
Growth hormone
Arthritis
Fine chemical
Erythropoietin
Surgery
Biosimilar
Golimumab
Etanercept
Infliximab
Adalimumab
Tocilizumab
Viscosupplementation
Rituximab
Monoclonal antibody
Certolizumab pegol
Natalizumab
...[+17]
Merck & Co., Inc.
1890
|
United States
|
50,000-100,000
|
http://www.merck.com.libproxy1.nus.edu.sg
|
Public Company
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
More
Biopharmaceutical
Drug
Medicine
Livestock
Clinical trial
Oncology drugs
Biotechnology
Monoclonal antibody
Genomics
Cardiovascular agent
Immunotherapy
Drug discovery
Cell culture
Infection drug
Infertility
Gastrointestinal agent
Laboratory testing
Antiviral drug
...[+15]
Monsanto Technology LLC
|
United States
|
-
|
-
|
Subsidiary Company
More
Lucky Co.
|
China
|
-
|
-
|
Private Company
More
Merial LLC
|
United States
|
-
|
-
|
Private Company
More
Pharmacia Corp.
1901
|
United States
|
10,000-50,000
|
-
|
Private Company
Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.
More
Botanical drug
Herb
Ophthalmology
Pharmacy
Oncology
Amgen, Inc.
1980
|
United States
|
10,000-50,000
|
http://www.amgen.com
|
Public Company
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.
More
Biopharmaceutical
TUMOR NECROSIS FACTOR BLOCKER
Medicine
Cancer chemotherapy
Molecular genetics
Rheumatoid arthritis
Autoimmune disease
Oncology drugs
Monoclonal antibody
Clinical trial
Immunotherapy
Bevacizumab
Cardiovascular agent
Adalimumab
Biosimilar
Genomics
Cancer immunotherapy
Antibody
Rituximab
...[+16]
Regents of the University of California
1868
|
United States
|
-
|
http://www.ucop.edu
|
Subsidiary Company
The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).
More
Pathology
Companion diagnostic
American Can Co.
|
United States
|
-
|
-
|
Private Company
The American Can Company was a manufacturer of tin cans. It was a member of the Tin Can Trust, that controlled a "large percentage of business in the United States in tin cans, containers, and packages of tin." American Can Company ranked 97th among United States corporations in the value of World War II military production contracts. It was formerly a member of the Dow Jones Industrial Average from 1959–1991, though after 1987 it had renamed itself Primerica, a financial conglomerate which had divested itself of its packaging arm in 1986.
More
Tin can
Packaging engineering
Microservices
Metal
Mallinckrodt Veterinary, Inc.
|
United States
|
-
|
-
|
Subsidiary Company
Part of Mallinckrodt Plc, Mallinckrodt Veterinary, Inc. is an American company. The firm makes vaccines, growth agents and parasite-killing products. It was acquired by Schering-Plough Corp., a subsidiary of Merck & Co., Inc. since November 2009, from Mallinckrodt, Inc.(Old) on July 01, 1997 for $405 million.
More
Mallinckrodt
Medicine
Login to view more
People also interested in
Chemical engineeringPathologyOphthalmologyBiophysicsNeuroscienceBiomedicineInsulinClinical trialExosomeDiagnostic test
Keywords Quick Entry
Male genderCloud simulationAlangium platanifoliumViscous damperRegion of backgroundPositively charged particleNeointima FormationPalygorskiteEnergy schedulingInternal modelFast releaseAir managementAngiotensin receptor iiHierarchical network modelRf systemPentamethylcyclopentadieneCZTSScientific methodMonocrystalline siliconRubusBatch operationShunt capacitorsMesothelinResidual BlocksWide areaHydroquinone CompoundLong term durabilityRelational databaseNorphenylephrineMunicipal solid waste
View more
Page generation time: